{"organizations": [], "uuid": "502e83fcb0ad45d0f4ae838813737e054acba98c", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "https://fm.cnbc.com/applications/cnbc.com/resources/img/editorial/2018/03/23/105085926-C4zJ-arW8AAfpvy.1910x1000.jpg", "site_section": "http://www.cnbc.com/id/19746125/device/rss/rss.xml", "section_title": "Top News and Analysis (pro)", "url": "https://www.cnbc.com/2018/03/23/abbotts-alere-resolves-us-diagnostic-device-probe-for-33-point-2-million.html", "country": "US", "domain_rank": 767, "title": "Abbott's Alere resolves US diagnostic device probe for $33.2 million", "performance_score": 0, "site": "cnbc.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "blogs", "published": "2018-03-23T20:35:00.000+03:00", "replies_count": 0, "uuid": "502e83fcb0ad45d0f4ae838813737e054acba98c"}, "author": "", "url": "https://www.cnbc.com/2018/03/23/abbotts-alere-resolves-us-diagnostic-device-probe-for-33-point-2-million.html", "ord_in_thread": 0, "title": "Abbott's Alere resolves US diagnostic device probe for $33.2 million", "locations": [], "entities": {"persons": [{"name": "abbott", "sentiment": "negative"}], "locations": [{"name": "alere", "sentiment": "none"}, {"name": "us", "sentiment": "none"}], "organizations": [{"name": "alere", "sentiment": "negative"}, {"name": "modern medicine abbott", "sentiment": "negative"}, {"name": "abbott laboratories", "sentiment": "none"}, {"name": "justice department", "sentiment": "none"}, {"name": "mins ago reuters", "sentiment": "none"}, {"name": "u.s. justice department", "sentiment": "none"}, {"name": "alere  alere", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Alere has agreed to pay $33.2 million to resolve claims it knowingly sold unreliable diagnostic testing devices to hospitals prior to its acquisition by Abbott Laboratories last year, the U.S. Justice Department said on Friday.\nThe Justice Department said that Massachusetts-based Alere, from 2006 to 2012, sold its Triage-branded devices to hospitals that government healthcare programs paid for, despite receiving customer complaints about the erroneous results they produced.", "external_links": [], "published": "2018-03-23T20:35:00.000+03:00", "crawled": "2018-03-23T21:04:56.015+03:00", "highlightTitle": ""}